“Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital” (2022) University Heart Journal, 18(1), pp. 10–13. doi:10.3329/uhj.v18i1.57874.